Vectorite Biomedical

Vectorite Biomedical Debt/EBITDA

The Total Debt to EBITDA Ratio of Vectorite Biomedical (4170.TWO) as of Oct 9, 2026 is -0.22.

Debt/EBITDA

-0.22

Last updated:

Total Debt to EBITDA Ratio of Vectorite Biomedical is 2019 -0.22 . Total Debt to EBITDA Ratio of Vectorite Biomedical was 2018 0.00 . It decreases by % lower compared to the previous year.

The Vectorite Biomedical Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2014
-0.49 TWD
Jan 1, 2015
-0.35 TWD
Jan 1, 2016
-0.65 TWD
Jan 1, 2017
0.00 TWD
Jan 1, 2018
0.00 TWD
Jan 1, 2019
-0.22 TWD
The Vectorite Biomedical Debt/EBITDA history
YEARDebt/EBITDAYoY
-0.22—
0.00—
0.00-100.00%
-0.65+84.74%
-0.35-28.36%
-0.49—
Access this data via the Eulerpool API
Get Free API Key

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

Total Debt to EBITDA Ratio of Vectorite Biomedical is -0.22 in 2019.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Vectorite Biomedical since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Vectorite Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Vectorite Biomedical

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Vectorite Biomedical